Desq Long
Sign in

Company

Edgewise Therapeutics, Inc.

EWTX · CIK 0001710072

SEC FORM 4
$0.00

Edgewise Therapeutics, Inc. (EWTX)

Acquisition (code M) of 17,969 shares at $0.00 per share.

Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Edgewise Therapeutics, Inc. (EWTX)

Acquisition (code M) of 21,875 shares at $0.00 per share.

Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code M

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →

SEC FORM 4
$383,253.51

Edgewise Therapeutics, Inc. (EWTX)

Sale of 8,782 shares at $43.6408 per share.

Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →

SEC FORM 4
$361,315.26

Edgewise Therapeutics, Inc. (EWTX)

Sale of 8,276 shares at $43.6582 per share.

Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →

SEC FORM 4
$40,473.29

Edgewise Therapeutics, Inc. (EWTX)

Sale of 913 shares at $44.33 per share.

Reporting Person KOCH KEVIN · Officer Title President and CEO · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001185829-26-000001 · filed 2026-08-14 · View filing →